AB
AMPE

Amalgamated Bank’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Amalgamated Bank’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-106
Closed -$15K – 3312
2022
Q1 		$15K Sell
106
-9
-8% -$1.31K ﹤0.01% 2888
2021
Q4 		$20K Sell
115
-3
-3% -$1.12K ﹤0.01% 2145
2021
Q3 		$59K Sell
118
-2
-2% -$927 ﹤0.01% 2119
2021
Q2 		$60K Buy
+120
New +$64.5K ﹤0.01% 2154
2019
Q2 		– Sell
-49
Closed -$8K – 1817
2019
Q1 		$8K Buy
49
+2
+4% +$343 ﹤0.01% 1694
2018
Q4 		$6K Buy
+47
New +$7.21K ﹤0.01% 1628
2018
Q3 		– Sell
-42
Closed -$28K – 1661
2018
Q2 		$28K Buy
+42
New +$31.4K ﹤0.01% 1730

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amalgamated Bank's AMPE Position: Q2 2022 in Review

Amalgamated Bank sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 106 shares — an estimated $15K sold.

Amalgamated Bank first reported a position in AMPE in Q2 2018 and held it in 7 quarters. The position peaked at $60K in Q2 2021. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • Amalgamated Bank reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 106 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $15K.
  • Amalgamated Bank first reported a position in Ampio Pharmaceuticals Inc. in Q2 2018 and held it in 7 quarters.
  • Amalgamated Bank's Ampio Pharmaceuticals Inc. position peaked at $60K in Q2 2021.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.